Skip to main content
All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for CERUS CORPORATION

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $40,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 3
Budget/Appropriations

H.R.____/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.____/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

Defense

H.R.____/S.____ National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem